Tailored and compliant solutions from credible experts
Ensuring compliance and a robust regulatory strategy, we develop phase-appropriate qualification, characterization, and analytical method validation strategies appropriate to your stage of product development and assist in the preparation of global filings.
Phase appropriate validation
We offer consolidated phase-appropriate validation packages with fit-for-purpose methods and robust de novo assays that stand up to regulatory scrutiny.
Ensuring conformance with ICHQ7, our scientists ensure cGMP compliance and the highest levels of efficiency without compromising product quality or patient safety.
Based on our decades of regulatory experience, we will provide the best strategy for your molecule, regardless of its phase. We are here to support all your regulatory needs.
Process characterization
Ensuring the robustness and repeatability of your process and consistent quality of product, we utilize design of experiment (DOE) studies to ensure your process is fully understood and documented to support successful regulatory submissions.
Saving time and ensuring scalability, we are committed to quality excellence and designing and delivering tailored solutions with patient safety in mind.
Our team has expansive experience and capability to consider your process requirements, developing a series of protocols and regulatory strategies tailored to your molecule and desired function.
Analytical methods
Helping you meet regulatory and quality requirements, our experts provide guidance and design; execute; and document analytical method development, qualification, and validation programs to support even your most complex molecules.
Ensuring compliance throughout, we follow ICHQ2(R2) guidelines for method validation, delivering robust programs that meet your requirements.
Adaptable to your needs and standards, our expert analytical teams are fully integrated into your project, giving you access to data quickly. Collaboration between our analytical, and process and formulation teams ensure the development and validation of robust phase-appropriate methods.
Lifecycle management
To help promote innovation and continuous improvement Abzena has a framework following the ICH guidance ‘Q12 Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management’.
Working collaboratively alongside you, this will support the management of post approval Chemistry and Manufacturing Control (CMC) changes for your product.
We use a scientific and risk-based approach to inform your decision making, ensuring that post approval changes are fit for purpose. Our team are experienced in creating robust data packages that help facilitate regulatory review.
The asset you’re developing right now can make a real difference for human health. Let us apply our wealth of experience to accelerate and maximize its potential.
